Osimertinib clearly activates caspase-8, which, in general as DR4 does, works upstream of Bim in EGFRm NSCLC cells and triggers the extrinsic apoptotic pathway as we previously demonstrated 35, 41. Here, BCL2L11 is linked to non-small cell lung carcinoma.